BMB-101
BMB-101-201
Phase 2 small_molecule active
Quick answer
BMB-101 for Prader-Willi Syndrome is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Prader-Willi Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active